Hurlburt Elizabeth

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 77% 68% 82%
Transactions
15 27% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 12%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Hurlburt Elizabeth's trades of Helios Underwriting PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
331.90
Quantity 8,644
Value £3,392,499
Transaction date
Purchase
Price
486.45
Quantity 57,090
Value £2,840,032
Transaction date
Sale
Price
271.28
Quantity 58,556
Value £999,236
US CorMedix Inc. (CRMD)
Transaction date
Sale
Price
13.08
Quantity 41,121 -18.9%
Value US$537,863
US CorMedix Inc. (CRMD)
Transaction date
Sale
Price
13.51
Quantity 12,876 -6.8%
Value US$173,955
US CorMedix Inc. (CRMD)
Transaction date
Proposed sale
Price
13.50
Quantity 53,997
Value US$728,959
US CorMedix Inc. (CRMD)
Transaction date
Sale
Price
11.18
Quantity 140,027 -75.5%
Value US$1,565,670
US CorMedix Inc. (CRMD)
Transaction date
Proposed sale
Price
11.12
Quantity 140,027
Value US$1,556,416
Transaction date
Purchase
Price
1.84
Quantity 46,306
Value £84,972
Transaction date
Sale
Price
1.60
Quantity 12,450
Value £19,927
Transaction date
Sale
Price
1.60
Quantity 12,450
Value £19,920
Transaction date
Sale
Price
1.55
Quantity 13,000
Value £20,159
Transaction date
Purchase
Price
1.45
Quantity 20,700
Value £30,015
Transaction date
Sale
Price
1.55
Quantity 12,800
Value £19,846
US CorMedix Inc. (CRMD)
Transaction date
Sale
Price
6.92
Quantity 8,000 -100.0%
Value US$55,394
Transaction date
Sale
Price
1.65
Quantity 151,500
Value £250,005
Transaction date
Sale
Price
1.65
Quantity 151,500
Value £249,975
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-16 2026-07-10
B Purchase
8,644
331.90
£3,392,499 		8,644 331.90 £3,392,499
2026-04-10 2026-04-09
B Purchase
57,090
486.45
£2,840,032 		57,090 486.45 £2,840,032
2026-04-10 2026-04-09
S Sale
58,556
271.28
£999,236 		58,556 271.28 £999,236
2025-09-11 2025-09-11
US CorMedix Inc. (CRMD)
S Sale
41,121 -18.9%
13.08
US$537,863 		41,121 -18.9% 13.08 US$537,863
2025-09-11 2025-09-09
US CorMedix Inc. (CRMD)
S Sale
12,876 -6.8%
13.51
US$173,955 		12,876 -6.8% 13.51 US$173,955
2025-09-09 2025-09-09
US CorMedix Inc. (CRMD)
PrS Proposed sale
53,997
13.50
US$728,959 		53,997 13.50 US$728,959
2024-11-18 2024-11-14
US CorMedix Inc. (CRMD)
S Sale
140,027 -75.5%
11.18
US$1,565,670 		140,027 -75.5% 11.18 US$1,565,670
2024-11-14 2024-11-14
US CorMedix Inc. (CRMD)
PrS Proposed sale
140,027
11.12
US$1,556,416 		140,027 11.12 US$1,556,416
2024-07-17 2024-07-12
B Purchase
46,306
1.84
£84,972 		46,306 1.84 £84,972
2023-04-11 2023-04-06
S Sale
12,450
1.60
£19,927 		12,450 1.60 £19,927
2023-04-11 2023-04-06
S Sale
12,450
1.60
£19,920 		12,450 1.60 £19,920
2022-04-08 2022-04-07
S Sale
13,000
1.55
£20,159 		13,000 1.55 £20,159
2021-07-28 2021-07-27
B Purchase
20,700
1.45
£30,015 		20,700 1.45 £30,015
2021-06-02 2021-06-01
S Sale
12,800
1.55
£19,846 		12,800 1.55 £19,846
2021-05-25 2021-05-21
US CorMedix Inc. (CRMD)
S Sale
8,000 -100.0%
6.92
US$55,394 		8,000 -100.0% 6.92 US$55,394
2021-03-11 2021-03-10
S Sale
151,500
1.65
£250,005 		151,500 1.65 £250,005
2021-03-11 2021-03-10
S Sale
151,500
1.65
£249,975 		151,500 1.65 £249,975